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Angiomatoid fibrous histiocytoma is an uncommon soft-tissue tumor of intermediate malignancy that is often misdiagnosed
initially. As there is not one immunohistochemical marker that consequently stains positive or negative for angiomatoid fibrous
histiocytoma, molecular diagnostics are becoming more widely used. So far three translocations have been reported to arise in
angiomatoid fibrous histiocytoma: FUS-ATF1, EWSR1-CREB1, or EWSR1-ATF1. We present a case of angiomatoid fibrous his-
tiocytoma on the upper arm of a 40-year-old female, which was initially misdiagnosed as metastatic melanoma in a lymph node.
Revision of the pathology revealed an angiomatoid fibrous histiocytoma, which was later confirmed by a EWSR1-CREB1 trans-
location with molecular diagnostics. Furthermore, we review the relevant literature and provide an overview of all available case
reports in the past ten years. This case report illustrates the importance for pathologists of knowing the typical pathology features
of AFH and integrating immunohistochemical and molecular findings in order to prevent overdiagnosis of lymph node metastasis
of a malignancy.
1. Introduction
Angiomatoid fibrous histiocytoma (AFH) is a rare soft-tissue
tumor first described by Enzinger in 1979, occurring most
commonly in children and young adults [1]. It is classified by
the World Health Organization as a fibrohistiocytic tumor of
intermediate malignancy [2], with local recurrence rates of
11% and metastatic disease in 1% [3]. AFH develops most
frequently on the extremities (65%), followed by the trunk
(28%) and head and neck (7%) [4], and is clinically often
thought to represent lymphadenopathy, cyst, hemangioma,
or Kaposi or Ewing sarcoma [5–7]. Four main histological
features usually seen in AFH are a fibrous pseudocapsule, a
round or spindle fibrohistiocytic cell proliferation, a pseu-
doangiomatous pattern, and a plasmalymphocytic infiltrate
[5, 8]. The pathological analysis may, however, be diﬃcult
as the tumor may mimic lymph node metastasis of another
round or spindle cell malignancy, and specific immunohis-
tochemical stains that provide a conclusive diagnosis are
lacking [9]. The use of molecular diagnostics can be helpful
in establishing a diagnosis in these cases.
We present the case of a 40-year-old woman whose AFH
was initially diagnosed as a lesion suspicious for melanoma
metastasis. No primary tumor could be discovered after
thorough evaluation by other specialists, hence the pathology
of the tumor was revised. The final diagnosis was established
by means of immunohistochemistry and demonstration of a
specific translocation, EWSR1-CREB1 which is described in
AFH.
2. Case Report
A 40-year-old obese Caucasian woman with no relevant
medical history presented at another institution with a fast
growing, asymptomatic tumor of the left upper arm that had
appeared within several weeks. She was otherwise healthy
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Figure 1: (a) Pathologic review of the tumor showed fibrous septa and nodular texture surrounded by lymphocytic infiltrate. Hematoxylin
and eosin stain (12, 5x). (b) Detail image showing the absence of a capsular sinus. Hematoxylin and eosin stain (25x). (c) Image of excised
tumor showing fibrous septa and nodular texture surrounded by lymphocytic infiltrate. Hematoxylin and eosin stain (12, 5x). (d) Detail
image showing reticular appearance and atypical cytomorphology. Hematoxylin and eosin stain (100x).
and had no physical complaints, especially no loss of appe-
tite, weight loss, or night sweats. She had quit smoking 5
years ago and did not use any medication.
On clinical examination she had a normal blood pressure
and pulse. There was a small, fixed, and nontender subcuta-
neous tumor on the left upper arm of approximately 2.0 cm
in diameter. Inspection of the rest of the body revealed no
other suspicious lesions or lymph nodes. Diﬀerential diagno-
sis of the tumor included lipoma, cyst, venous malformation,
or lymph node malignancy upon which the lesion was
surgically removed.
A gray tan nodule measuring 1.2 cm was excised from the
subcutaneous fat of the patients’ left upper arm. Pathology
revealed a radically excised structure resembling a lymph
node in which a tumoral process was seen, consisting of
a diﬀuse proliferation of atypical spindle cells. The atypia
was specified by undefined cell borders, an amphophilic
cytoplasm, large polygonal nuclei and several in part atypical
mitoses (Figure 1(d)). Complementary immunohistochemi-
cal stains were negative for HMB-45, KL1, cytokeratin AE1/3,
and SMa. There was focal positivity for S100 and Melan A
(Figure 2(a)) leading to a presumptive diagnosis elsewhere of
a melanoma metastasis.
Further clinical investigation of the patient by a dermato-
logist, ophthalmologist, gynecologist, and surgeon revealed
no lesions suspect for the primary tumor. A CT chest and
abdomen and PET CT scan also showed no suspect lesions.
Due to uncertainty about the diagnosis and prognosis
of the patient, she was referred to the Radboud University
NijmegenMedical Centre (RUNMC) for a second opinion, at
which the pathology of the tumor was revised. We confirmed
the signs of cellular atypia as described elsewhere, within
a spindle cell proliferation with a nodular texture, covered
by normal dermis and epidermis without an intraepidermal
melanocytic proliferation. The tumor nodules were partially
surrounded by fibrous septa and densely vascularized by a
capillary network (Figures 1(a) and 1(c)). A dense and exten-
sive lymphatic infiltrate with no evident subcapsular sinus
surrounded the spindle cell proliferation (Figure 1(b)).
We considered upon revision the S100 and Melan A
staining to be negative in the lesional cells. More immunohis-
tochemical staining, complementary to the previous stains,
was performed. The neoplastic cells were positive for CD99
and EMA (Figure 2(b)) and to a lesser extent for CD31. Some
capillary vessels stained positive for desmin; however, the
tumor cells did not. Other negative stains included CD34,
CD30, CD35, Cd10, HHV8, S100, MITF, CD79a, CD20,
CD3, CD2, and CD21.
Conclusion of revision of the pathology showed that the
tumor, that was initially thought to consist of metastatic
melanoma within a lymph node, was in fact a diﬀerent type
of spindle cell tumor surrounded by an extensive lymphatic
infiltrate and densely vascularized by capillaries and a few
larger vessels. Given the age of the patient and location of
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Figure 2: (a)Melan A stain showing focal positivity. Melan A stain (200x). (b) The neoplastic cells were positive for EMA staining. EMA stain
(25x). (c) Electrophoretogram of direct sequencing of the junctional region of the EWSR1-CREB1 fusion transcript, with in-frame fusion.
The schematic overview shows the EWSR1 nucleotides/amino acids in black and the CREB1 nucleotides in red.
the lesion combined with the histopathologic findings, the
diagnosis was adjusted into angiomatoid fibrous histiocy-
toma. Additional molecular research, performed in support
of this diagnosis, showed a gene fusion mutation of EWSR1-
CREB1 t(2;22)(q33;q12) (Figure 2(c)), while mutations in
BRAF and NRAS genes, common in cutaneous melanoma,
could not be detected.
3. Discussion
Angiomatoid fibrous histiocytoma is a mesenchymal tumor
of intermediate malignancy of unknown diﬀerentiation.
Although it was originally reported to arise most frequently
on the extremities of children and young adults, many case
reports found in the literature describe AFHs developing on
other sites of the body, such as the mediastinum [4], bone
[10], intrapulmonal [11], or intracranial [11]. A complete
overview of sites of origin of AFH in available case reports
published in the past 10 years can be found in Table 1. In
total 18 case reports on AFH were found in the past decade.
In addition some case series were reported [5, 9].
Table 1 shows that most AFHs are found in patients in
the first 3 decades of life, though patients aged 80 or more
with AFH have also been reported [4, 7]. AFH on the upper
extremity of a healthy middle-aged woman can therefore be
considered a classic presentation of this tumor.
Due to the fact that AFHs are rare, the typical histological
features are relatively unknown to pathologists which can
lead to an erroneous diagnosis ofmalignant disease (Table 1).
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Table 1: Overview of all case reports on angiomatoid fibrous histiocytoma between 2002 and 2012.
Article
Patient
age
Localization Diﬀerential diagnosis Immunohistochemical staining
Molecular
diagnostics
(1) Mansfield et al.,
2010 [12]
M, 25 Left axilla
Metastatic melanoma,
rhabdomyosarcoma
Positive: vimentin, EMA, and CD68
Negative: S100, Melan A, HMB45,
myogenin, desmin, smooth muscle actin,
and keratin
—
(2) Song et al.,
2011 [13]
F, 23 Palatum
Necrotizing
sialometaplasia, tertiary
syphilis, and Wegener’s
granulomatosis
Positive: proliferating cell nuclear antigen,
S-100, CD31, and desmin
Negative: α-smooth muscle actin, p53,
survivin, CD68, and TNF-α
—
(3) Moura et al.,
2011 [4]
M, 80 Mediastinum —
Positive: EMA and desmin
Negative: S100, Melan A, smooth muscle
actin, anticytokeratin CAM 5.2,
anticytokeratin OSCAR, chromogranin,
synaptophysin, myogenin, and glial
fibrillary acidic protein
EWSR1/CREB1
fusion
(4) Ajlan et al.,
2010 [14]
F, 28
F, 85
Left shoulder
Right upper arm
— — —
(5) Cernik et al.,
2009 [15]
M, 6 Left forearm Hemangioma
Negative: CD34, reticulin, and
pancytokeratin
—
(6) Mangham et al.,
2010 [10]
M, 11 Right upper arm —
Positive: desmin, EMA, and cytokeratin
(AE1/AE3)
Negative: CD31, CD34, CD45, S100, smooth
muscle actin, HMB45, myoD1, myoglobin,
myf4, and myogenin
EWSR1-ATF1
fusion
(7) Ochalski et al.,
2010 [11]
M, 35 Intracranial Meningioma
Positive: vimentin, desmin, and CD68
Negative: MYOD1, myoglobin, and
myogenin
Rearranged
ESWR1 gene
(8) Ren et al.,
2009 [16]
M, 46 Intrapulmonal —
Positive: EMA, desmin, CD163, and CD68
Negative: S100 protein, smooth muscle
actin, CD34, cytokeratin, anaplastic
lymphoma kinase-1, CD21, CD23, and
immunoglobulin light chains
EWS/ATF1 gene
fusion
(9) Weinreb et al.,
2008 [17]
M, 8 Scalp
Pleomorphic fibrous
histiocytoma
Positive: CD99, Factor 3a, desmin, and SMA
Negative: S100, pankeratin
EWSR1
translocation on
22q12
(10) Martelli et al.,
2008 [6]
F, 7
(HIV+)
Right knee
Benign epithelial cyst,
mesenchymal tumor
Positive: desmin
Negative: S100, CD68, and smooth muscle
actin
—
(11) Dunham et al.,
2008 [18]
M, 25 Intracranial —
Positive: v imentin, CD68, S100, CD31, and
desmin
Negative: CD34, glial fibrillary acidic
protein, neurofilament, synaptophysin,
CAM 5.2, HMB-45, and progesterone
receptor stains
EWS/ATF-1 gene
fusion
(12) Koletsa et al.,
2007 [19]
F, 28 Left leg —
Positive: vimentin, CD68
Negative: SMA, desmin, CD34, CD31, factor
VIII-related antigen, S-100, EMA, and
cytokeratins cam5.2, AE1/AE3 and 17
—
(13) Hallor et al.,
2007 [20]
M, 11
M, 10
Paravertebral
Right clavicular
region
— —
EWSR1-ATF1
fusion genes (2x)
(14) Pratibha and
Ahmed, 2006 [21]
F, 13 Left lower jaw —
Positive: CD68
Negative: desmin and keratin
—
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Table 1: Continued.
Article
Patient
age
Localization Diﬀerential diagnosis Immunohistochemical staining
Molecular
diagnostics
(15) Lai et al.,
2006 [22]
F, 28 Neck — — —
(16) Hallor et al.,
2005 [23]
M, 9 Right elbow
Reticulum cell tumor,
Rosai-Dorfman disease
Positive: CD68, vimentin
Negative: S100, CD1a, cytokeratin, EMA,
CD21, CD31, CD34, HMB45, and Melan A
EWSR1-ATF1
fusion gene
(17) Hothi et al.,
2004 [24]
M, 13 Left thigh — — —
(18) Raddaoui et al.,
2002 [25]
M, 38 Right upper arm High-grade sarcoma
Positive: vimentin, calponin, CD99, and
desmin
Negative: keratin AE-1/AE-3, S100, CD34,
CD57, macrophage specific marker, MSA,
and SMA
FUS/ATF1 fusion
gene
This is most likely due to the typical dense lymphocytic infil-
trate surrounding the tumor, suggestive of a tumor metas-
tasis to a lymph node. In one other reported case (case 1,
Table 1), as in our case, metastatic melanoma was a diﬀeren-
tial diagnostic consideration.
In our case the initial diagnosis was metastatic melanoma
in a lymph node, due to the dense capsule and the surround-
ing plasmalymphocytic infiltrate and focal aspecific staining
of lesional cells for melanocytic markers [12, 26, 27]. Care-
ful revision eventually revealed the absence of structures nor-
mally found in lymph nodes, such as a subcapsular sinus and
triggered further research on the origin of the present tumor.
Interpreting immunohistochemical staining results can
be complex, as there is not one immunohistochemical mar-
ker that consequently stains positive for AFH. As indicated
in Table 1, the majority of studies have reported AFHs to
stain positive for CD68 [8, 28], desmin, EMA, and vimentin.
Within a small percentage of AFHs other muscle markers
such as HHF-35 and calponin also stain positive [29]. The
AFH in the present case report showed positive staining for
CD99 and EMA, though desmin seemed positive only in
the surrounding capillary epithelium and CD68 in the intra-
lesional dendrites. Double immunoreactivity for EMA and
desmin is reported to be a diagnostic clue for AFH [5].
Nevertheless, immunohistochemistry has a limited role
in establishing the diagnosis of AFH. The knowledge of the
existence of this rare entity with its typical pathology features
is therefore vital in preventing misdiagnosis.
As the molecular genetics of AFH become increasingly
understood, genetic testing is utilizedmore widely to support
the diagnosis of this entity. There are three translocations
resulting in fusion genes associated with AFH: FUS/ATF
(t(12;16)(q13;p11)) [30], EWSR1/ATF1 (t(12;22)(q13;q12))
[23], and EWSR1/CREB1 (t(2;22)(q33;q12)) fusion genes
[31]. In available case reports published in the past 10 years,
the EWSR1/ATF1 (t(12;22)(q13;q12) fusion was most com-
monly found (Table 1). In a series of 9 AFH Antonescu et al.
reported that EWSR1-CREB1 was the predominant gene
fusion in AFH present in 8/9 cases [31]. In our case, the
patient was also tested positive for the EWSR1/CREB1
(t(2;22)(q33;q12)) fusion gene, hereby supporting the diag-
nosis of AFH. The EWSR1-CREB1 translocation is not uni-
que to AFH but also present in clear cell sarcoma of the gas-
trointestinal tract and soft tissue [32].
In conclusion, AFH is a rare disease that is often misdi-
agnosed initially. Prognosis is generally good following wide
surgical excision, with low potential of local recurrence and
metastasis.
Our case report illustrates the importance for patholo-
gists of knowing the typical pathology features of AFH and
integrating immunohistochemical and molecular findings in
order to prevent overdiagnosis of lymph node metastasis of a
malignancy.
One year following excision, our patient is well without
signs of local recurrence or metastasis.
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